These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35441357)

  • 21. Establishment of novel patient-derived models of dermatofibrosarcoma protuberans: two cell lines, NCC-DFSP1-C1 and NCC-DFSP2-C1.
    Oyama R; Kito F; Qiao Z; Sakumoto M; Shiozawa K; Toki S; Yoshida A; Kawai A; Kondo T
    In Vitro Cell Dev Biol Anim; 2019 Jan; 55(1):62-73. PubMed ID: 30411273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. iPSC-Derived Neoantigen-Specific CTL Therapy for Ewing Sarcoma.
    Ishii M; Ando J; Yamazaki S; Toyota T; Ohara K; Furukawa Y; Suehara Y; Nakanishi M; Nakashima K; Ohshima K; Nakauchi H; Ando M
    Cancer Immunol Res; 2021 Oct; 9(10):1175-1186. PubMed ID: 34385178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma.
    Koelsche C; Kriegsmann M; Kommoss FKF; Stichel D; Kriegsmann K; Vokuhl C; Grünewald TGP; Romero-Pérez L; Kirchner T; de Alava E; Diaz-Martin J; Hartmann W; Baumhoer D; Antonescu CR; Szuhai K; Flucke U; Dirksen U; Pfister SM; Jones DTW; Mechtersheimer G; von Deimling A
    J Cancer Res Clin Oncol; 2019 May; 145(5):1273-1281. PubMed ID: 30895378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment and characterization of a novel patient-derived cell line of dedifferentiated liposarcoma, NCC-DDLPS6-C1.
    Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Ono T; Akiyama T; Nakagawa R; Kamio S; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
    Hum Cell; 2022 Jul; 35(4):1270-1278. PubMed ID: 35604485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ewing-like sarcoma: An emerging family of round cell sarcomas.
    Renzi S; Anderson ND; Light N; Gupta A
    J Cell Physiol; 2019 Jun; 234(6):7999-8007. PubMed ID: 30257034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis.
    Sánchez-Molina S; Figuerola-Bou E; Blanco E; Sánchez-Jiménez M; Táboas P; Gómez S; Ballaré C; García-Domínguez DJ; Prada E; Hontecillas-Prieto L; M Carcaboso Á; Tirado ÓM; Hernández-Muñoz I; de Álava E; Lavarino C; Di Croce L; Mora J
    Sci Adv; 2020 Oct; 6(43):. PubMed ID: 33097530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment and characterization of NCC-LMS3-C1: a novel patient-derived cell line of leiomyosarcoma.
    Yoshimatsu Y; Noguchi R; Osaki J; Sin Y; Tsuchiya R; Ono T; Akiyama T; Adachi Y; Tanzawa Y; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2024 Jan; 37(1):337-344. PubMed ID: 37907774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
    Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
    Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment and characterization of a novel cell line, NCC-MFS1-C1, derived from a patient with myxofibrosarcoma.
    Kito F; Oyama R; Sakumoto M; Shiozawa K; Qiao Z; Toki S; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2019 Apr; 32(2):214-222. PubMed ID: 30737712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment and characterization of NCC-ASPS2-C1: a novel patient-derived cell line of alveolar soft part sarcoma.
    Osaki J; Noguchi R; Yanagihara K; Ono T; Adachi Y; Iwata S; Toda Y; Sekita T; Kobayashi E; Kojima N; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2024 May; 37(3):865-873. PubMed ID: 38478355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. STAG2 mutations alter CTCF-anchored loop extrusion, reduce cis-regulatory interactions and EWSR1-FLI1 activity in Ewing sarcoma.
    Surdez D; Zaidi S; Grossetête S; Laud-Duval K; Ferre AS; Mous L; Vourc'h T; Tirode F; Pierron G; Raynal V; Baulande S; Brunet E; Hill V; Delattre O
    Cancer Cell; 2021 Jun; 39(6):810-826.e9. PubMed ID: 33930311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment and characterization of NCC-PS1-C1: a novel cell line of pleomorphic sarcoma from a patient after neoadjuvant radiotherapy.
    Akiyama T; Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Ono T; Sugaya J; Kobayashi E; Yoshida A; Ohtori S; Kawai A; Kondo T
    Hum Cell; 2022 Nov; 35(6):2011-2019. PubMed ID: 36103079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.
    He T; Surdez D; Rantala JK; Haapa-Paananen S; Ban J; Kauer M; Tomazou E; Fey V; Alonso J; Kovar H; Delattre O; Iljin K
    Gene; 2017 Jan; 596():137-146. PubMed ID: 27760381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment and characterization of NCC-DDLPS5-C1: a novel patient-derived cell line of dedifferentiated liposarcoma.
    Sin Y; Yoshimatsu Y; Noguchi R; Tsuchiya R; Ono T; Akiyama T; Iwata S; Sugaya J; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2022 May; 35(3):936-943. PubMed ID: 35292923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation/migration choices in Ewing sarcoma cells.
    Franzetti GA; Laud-Duval K; van der Ent W; Brisac A; Irondelle M; Aubert S; Dirksen U; Bouvier C; de Pinieux G; Snaar-Jagalska E; Chavrier P; Delattre O
    Oncogene; 2017 Jun; 36(25):3505-3514. PubMed ID: 28135250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment and characterization of NCC-SS4-C1: a novel patient-derived cell line of synovial sarcoma.
    Tsuchiya R; Yoshimatsu Y; Noguchi R; Ono T; Sei A; Takeshita F; Sugaya J; Iwata S; Yoshida A; Ohtori S; Kawai A; Kondo T
    Hum Cell; 2021 May; 34(3):998-1007. PubMed ID: 33611700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmaceutical Interference of the EWS-FLI1-driven Transcriptome By Cotargeting H3K27ac and RNA Polymerase Activity in Ewing Sarcoma.
    Heisey DAR; Jacob S; Lochmann TL; Kurupi R; Ghotra MS; Calbert ML; Shende M; Maves YK; Koblinski JE; Dozmorov MG; Boikos SA; Benes CH; Faber AC
    Mol Cancer Ther; 2021 Oct; 20(10):1868-1879. PubMed ID: 34315769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary round cell sarcomas of the urinary bladder with EWSR1 rearrangement: a multi-institutional study of thirteen cases with a review of the literature.
    Baisakh MR; Tiwari A; Gandhi JS; Naik S; Sharma SK; Balzer BL; Sharma S; Peddinti K; Jha S; Sahu PK; Pradhan D; Geller M; Amin MB; Dhillon J; Mohanty SK
    Hum Pathol; 2020 Oct; 104():84-95. PubMed ID: 32798549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival.
    Tilan JU; Krailo M; Barkauskas DA; Galli S; Mtaweh H; Long J; Wang H; Hawkins K; Lu C; Jeha D; Izycka-Swieszewska E; Lawlor ER; Toretsky JA; Kitlinska JB
    Cancer; 2015 Mar; 121(5):697-707. PubMed ID: 25387699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromosomal localization of Ewing sarcoma EWSR1/FLI1 protein promotes the induction of aneuploidy.
    Park H; Kim H; Hassebroek V; Azuma Y; Slawson C; Azuma M
    J Biol Chem; 2021; 296():100164. PubMed ID: 33293370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.